ScreenerHero

VRPXVirpax Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · virpaxpharma.com
0.0002USD0.00%Mkt Cap: 248 $P/E: —

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatment…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap248 $
Enterprise Value-1.51M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.07M $
Revenue/Share—
Last Price0.0002 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-71.00
EPS (Forward)-0.90
52W Range
0.00010% of range0.1000
52W High0.1000 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1320.61%
ROA-775.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.71M $
CapEx (TTM)—
FCF Margin—
FCF Yield-4943741.13%
Net Debt-1.51M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.63
Quick Ratio0.61
Book Value/Sh-1.5340 USD
Cash/Share1.424 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateMar 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.24M
Float1.05M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Float1.81%
Short % Out.1.81%
Shares Short23.08K
Short (prev mo.)62.88K
Technical
SMA 500.0054 (-96.3%)
SMA 2000.0087 (-97.7%)
Beta-16.33
S&P 52W Chg18.16%
Avg Vol (30d)406
Avg Vol (10d)514
Technical Indicators
RSI (14)19.5
MACD-0.0015
MACD Signal-0.0018
MACD Hist.+0.0002
BB Upper0.0003 USD
BB Middle0.0001 USD
BB Lower-0.0000 USD
BB Width268.66%
ATR (14)0.0004 USD
Vol Ratio (20d)0.00x